Brazil
Canada
Germany
Japan
Information
Information
You are viewing the part of this website that is designated for the publication of documents and information in connection with the offer for Horizon Therapeutics plc by Amgen.
Offer and Related Documents
December 12, 2022
Confidentiality Agreement 1.2 MB
December 12, 2022
Rule 2.4 Announcement 39.6 KB
December 12, 2022
Transaction Agreement 1.5 MB
December 12, 2022
January 23, 2023
Definitive Proxy Statement 1.9 MB
January 23, 2023
Form of Proxy - Scheme Meeting 63.2 KB
January 23, 2023
Form of Proxy - EGM 202.5 KB
January 23, 2023
Rule 17(a) Announcement 581.8 KB
January 23, 2023
Rule 17(b) Announcement 581.8 KB
February 1, 2023
Form 8-K (FTC Second Request) 60.5 KB
February 17, 2023
Definitive Additional Materials 289.9 KB
February 24, 2023
Rule 17(c) Announcement 491.9 KB
February 24, 2023
Rule 15 Documents
January 27, 2023
Rule 15 Proposal 351.1 KB
January 27, 2023
January 27, 2023
Rule 15 (c) Announcement 398.8 KB
April 17, 2023
Constitutional Documents
Financial Information of Horizon
January 23, 2023
January 23, 2023
January 23, 2023
January 23, 2023
January 23, 2023
Financial Information of Amgen
January 23, 2023
January 23, 2023
January 23, 2023
January 23, 2023
January 23, 2023
Proxy Statement Consent Letters
January 23, 2023
January 23, 2023
January 23, 2023
January 23, 2023
January 23, 2023
Financing Documents
January 23, 2023
January 23, 2023
Other
December 12, 2022
Investor Email 151.3 KB
December 13, 2022
January 23, 2023
January 23, 2023
May 17, 2023